Substance active (DCI)
- facteur Willebrand humain + facteur VIII de coagulation humain
Informations techniques
Exploitant
français du Fractionnement et des Biotechnologies
Présentation
WILSTART, poudres et solvants pour solution injectable
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
Dh78WCnDmw68Bu4n
Écouter
